Haptoglobin phenotypes in epilepsy

Clinical Chemistry

Volumn 50, Issue 6, 2004, Pages 1095-1097

  Sadrzadeh, Sayed M H ^a   Saffari, Yasi ^a   Bozorgmehr, Jafar ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE PHASE PROTEIN; C REACTIVE PROTEIN; HAPTOGLOBIN;

ADULT; AGED; ARTICLE; BLOOD COMPONENT; CONTROLLED STUDY; CORRELATION ANALYSIS; EPILEPSY; FEMALE; GEL ELECTROPHORESIS; HUMAN; IMMUNOPEROXIDASE STAINING; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PROTEIN BLOOD LEVEL; RECURRENT DISEASE; SEIZURE; STATISTICAL SIGNIFICANCE;

ADULT; AGED; AGED, 80 AND OVER; EPILEPSY; FEMALE; HAPTOGLOBINS; HUMANS; MALE; MIDDLE AGED; PHENOTYPE;

EID: 2642535961     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/clinchem.2003.028001     Document Type: Article

References (29)

1. Brodie MJ, Dichter MA. Antiepileptic drugs. N Engl J Med 1996;334:168-75.
2. Brodie MJ, Shorvon SD, Canger R, Halasz P, Johannessen S, Thompson P, et al. Commission on European Affairs: appropriate standards of epilepsy care across Europe: ILEA. Epilepsia 1997;38:1245-50.
3. Loiseau P, Jallon p. Post-traumatic epilepsy. Prog Neurol Surg 1981;10:323-8.
4. Rosen AD, Frumin NV. Focal epileptogenesis after intracortical hemoglobin injection. Exp Neurol 1979;66:277-84.
5. Hammond EJ, Ramsay RE, Villarreal HJ, Wilder BJ. Effects of intracortical injection of blood and blood component in the electrocorticogram. Epilepsia 1980;21:3-14.
6. Willmore LJ, Sypert GW, Munson J. Chronic focal epileptiform discharges induced by injection of iron into rat and cat cortex. Science 1978;200:1501-3.
7. Fairbanks V, Beutler E. Iron metabolism. In: Beutler E, ed. Hematology, 6th ed. New YorK: McGraw-Hill 2000:295-305.
8. Wassell J. Haptoglobin: function and polymorphism. Clin Lab 2000;46:547-52.
9. Javid J. Human haptoglobins. Curr Top Hematol 1978;1:151-92.
10. Black JA, Dixon GH. Amino-acid sequence of α chains of human haptoglobins. Nature 1968;218:738-41.
11. Langlois MR, Delanghe JR. Biological and clinical significance of haptoglobin polymorphism in humans. Clin Chem 1996;42:1589-600.
12. Gutteridge JM. The antioxidant activity of haptoglobin towards haemoglobin-stimulated lipid peroxidation. Biochim Biophys Acta 1987;917:219-23.
13. Cid MC, Grant DS, Hoffman GS, Auerbach R, Fauci AS, Kleinman HK. Identification of haptoglobin as an angiogenic factor in sera from patients with systemic vasculitis. J Clin Invest 1993;91:977-85.
14. Bowman BH. Haptoglobin. In: Bowman BH, ed. Hepatic plasma proteins. San Diego: Academic Press, 1993:159-67.
15. Arredouani M, Matthijs P, Van Hoeyveld E, Kasran A, Baumann H, Ceuppens JL, et al. Haptoglobin directly affects T cells and suppresses T helper cell type 2 cytokine release. Immunology 2003;108:144-51.
16. Smithies O. Zone electrophoresis in starch gels: group variations in the serum proteins of normal adults. Biochem J 1955;61:629-41.
17. Ledue TB, Weiner DL, Sipe J, Poulin SE, Collins MF, Rifai N. Analytical evaluation of particle-enhanced immunonephelometric assays for C-reactive protein, serum amyloid A, and mannose binding protein in human serum. Ann Clin Biochem 1998;35:745-53.
18. Thompson KJ, Shoham S, Connor JR. Iron and neurodegenerative disorders. Brain Res Bull 2001;55:155-64.
19. Sadrzadeh SM, Graf E, Ranter SS, Hallaway PE, Eaton JW. Hemoglobin. A biologic Fenton reagent. J Biol Chem 1984;259:14354-6.
20. Panter SS, Sadrzadeh SM, Hallaway PE, Haines JL, Anderson VE, Eaton JW. Hypohaptoglobinemia associated with familial epilepsy. J Exp Med 1985;161:748-54.
21. Repine JE, Eaton JW, Anders MW, Hoidal JR, Fox RB. Generation of hydroxyl radical by enzymes, chemicals and human phagocytes in vitro: detection using the anti-inflammatory agent, dimethyl sulfoxide (DMSO). J Clin Invest 1979;64:1642-51.
22. Rosen H, Klebanoff SJ. Role of iron and ethylenediaminetetraacetic acid in the bactericidal activity of a superoxide anion-generating system. Arch Biochem Biophys 1979;208:512-9.
23. Sadrzadeh SM, Eaton JW. Hemoglobin-mediated oxidant damage to the central nervous system requires endogenous ascorbate. J Clin Invest 1988;82:1510-5.
24. Sadrzadeh SMH, Anderson DK, Panter SS, Hallaway PE, Eaton JW. Hemoglobin potentiates central nervous system damage. J Clin Invest 1987;79:662-4.
25. Gabray C, Kushner I. Acute phase proteins and other systemic responses to inflammation [Erratum in: N Engl J Med 1999;340:1376]. N Engl J Med 1999;340:448-54.
26. Langlois MR, Martin ME, Boelaert JR, Beaumont C, Taes YE, De Buyzere ML. et al. Haptoglobin phenotype 2-2 overrepresentation in Cys282Tyr hemochromatotic patients. J Hepatol 2001;35:707-11.
27. Kristiansen M, Graversen JH, Jacobsen C, Sonne O, Hoffman HJ, Law SK, et al. Identification of the haemoglobin scavenger receptor. Nature 2001;409:198-201.
28. Roguin A, Ribichini F, Ferrero V, Matullo G, Herer P, Wijns W, et al. Haptoglobin phenotype and the risk of restenosis after coronary artery stent implantation. Am J Cardiol 2002;89:806-10.
29. Raley MJ, Loegering DJ. Role of an oxidative stress in the macrophage dysfunction caused by erythrophagocytosis. Free Radic Biol Med 1999;27:1455-64.